ArticleInternational journal of clinical pharmacy2016
Mental health pharmacists views on shared decision-making for antipsychotics in serious mental illness.
Article in International journal of clinical pharmacy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 3 syntheses or guidelines pooled it, 50 citations in OpenAlex.
- A meta-ethnography of shared decision-making in mental health care from the perspective of staff and service users.BMC health services research · 2024Pooled it
- Shifting Perspectives on the Challenges of Shared Decision Making in Mental Health Care.Community mental health journal · 2024Pooled it
- Mapping modifiable determinants of medication adherence in bipolar disorder (BD) to the theoretical domains framework (TDF): a systematic review.Psychological medicine · 2021Pooled it
- Lived experiences of shared decision-making in young adults prescribed antipsychotics: a qualitative interview study.International journal of clinical pharmacy · 2026Article
- Bridging the Gap Between Efficacy and Practice: A Systematic Review of Shared Decision-Making in Severe Mental Illness.Journal of multidisciplinary healthcare · 2026Review
- Review
- From Idealist to Realist-Designing and Implementing Shared Decision-Making Interventions in the Choice of Antipsychotic Prescription in People Living with Psychosis (SHAPE): A Realist Review.Schizophrenia bulletin · 2025Review
- Experiences in Accessing Treatment Among Females with Schizophrenia: A Qualitative Study from Turkey.Healthcare (Basel, Switzerland) · 2025Article
- A realist review of medication optimisation of community dwelling service users with serious mental illness.BMJ quality & safety · 2024Review
- Article
- Shared decision making and associated factors among patients with psychotic disorders: a cross-sectional study.BMC psychiatry · 2023Article
- Overview of this issue: "clinical pharmacy impacting mental health delivery and outcomes".International journal of clinical pharmacy · 2023Article
- The role of pharmacists in supporting service users to optimise antipsychotic medication.International journal of clinical pharmacy · 2023Article
- What are patients' experiences of discontinuing clozapine and how does this impact their views on subsequent treatment?BMC psychiatry · 2023Article
- Shared decision-making practices and patient values in pharmacist outpatient care for rheumatic disease: A multiple correspondence analysis.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2023Article
- Medication optimisation in severe mental illness (MEDIATE): protocol for a realist review.BMJ open · 2022Article
- The role of trust and hope in antipsychotic medication reviews between GPs and service users a realist review.BMC psychiatry · 2021Review
- Shared decision making for adults with severe mental illness: A concept analysis.Japan journal of nursing science : JJNS · 2020Review
- Article
- Attitudes toward concordance and self-efficacy in decision making: a cross-sectional study on pharmacist-patient consultations.Patient preference and adherence · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background People diagnosed with serious mental illnesses (SMIs) such as schizophrenia and bipolar affective disorder are frequently treated with antipsychotics. National guidance advises the use of shared decision-making (SDM) in antipsychotic prescribing. There is currently little data on the opinions of health professionals on the role of SDM. Objective To explore the views and experiences of UK mental health pharmacists regarding the use of SDM in antipsychotic prescribing in people diagnosed with SMI. Setting The study was conducted by interviewing secondary care mental health pharmacists in the UK to obtain qualitative data. Methods Semi-structured interviews were recorded. An inductive thematic analysis was conducted using the method of constant comparison. Main outcome measure Themes evolving from mental health pharmacists on SDM in relation to antipsychotic prescribing in people with SMI. Results Thirteen mental health pharmacists were interviewed. SDM was perceived to be linked to positive clinical outcomes including adherence, service user satisfaction and improved therapeutic relations. Despite more prescribers and service users supporting SDM, it was not seen as being practised as widely as it could be; this was attributed to a number of barriers, most predominantly issues surrounding service user's lacking capacity to engage in SDM and time pressures on clinical staff. The need for greater effort to work around the issues, engage service users and adopt a more inter-professional approach was conveyed. Conclusion The mental health pharmacists support SDM for antipsychotic prescribing, believing that it improves outcomes. However, barriers are seen to limit implementation. More research is needed into overcoming the barriers and measuring the benefits of SDM, along with exploring a more inter-professional approach to SDM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.